Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway.
暂无分享,去创建一个
[1] M. Linton,et al. Recycling of Apolipoprotein E in Mouse Liver* , 1999, The Journal of Biological Chemistry.
[2] J. Heeren,et al. Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. , 1999, Journal of cell science.
[3] N. Fidge. High density lipoprotein receptors, binding proteins, and ligands. , 1999, Journal of lipid research.
[4] B. Middleton,et al. Elevation of cyclic AMP by iloprost and prostaglandin E1 increases cholesterol efflux and the binding capacity for high-density lipoproteins in human fibroblasts. , 1998, Biochimica et biophysica acta.
[5] H. Brewer,et al. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[6] Yong Ji,et al. Scavenger Receptor BI Promotes High Density Lipoprotein-mediated Cellular Cholesterol Efflux* , 1997, The Journal of Biological Chemistry.
[7] K. Kondo,et al. Cloning and Characterization of HB2, a Candidate High Density Lipoprotein Receptor , 1997, The Journal of Biological Chemistry.
[8] F. Reimann,et al. Clathrin-mediated endocytosis of high density lipoprotein3 in human intestinal Caco-2 cells. A post-embedding immunocytochemical study. , 1997, Biochimica et biophysica acta.
[9] A. Mendez,et al. Apolipoprotein-mediated cellular cholesterol and phospholipid efflux depend on a functional Golgi apparatus. , 1996, Journal of lipid research.
[10] S. Yokoyama,et al. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. , 1996, Journal of lipid research.
[11] Jonathan D. Smith,et al. Cyclic AMP Induces Apolipoprotein E Binding Activity and Promotes Cholesterol Efflux from a Macrophage Cell Line to Apolipoprotein Acceptors* , 1996, The Journal of Biological Chemistry.
[12] B. Perret,et al. High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). , 1996, Biochemistry.
[13] A. vonEckardstein. Cholesterol efflux from macrophages and other cells. , 1996 .
[14] H. Hidaka,et al. Ca2+ signaling and intracellular Ca2+ binding proteins. , 1996, Journal of biochemistry.
[15] A. Brownawell,et al. Calcium-dependent binding of the plasma protein apolipoprotein A-I to two members of the annexin family. , 1996, Biochemistry.
[16] O. Andersson,et al. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] F. Maxfield,et al. Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. , 1994, Journal of cell science.
[18] H. Pollard,et al. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. , 1994, Biochimica et biophysica acta.
[19] R. G. Anderson,et al. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation , 1993, The Journal of cell biology.
[20] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[21] W. J. Johnson,et al. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. , 1992, Journal of lipid research.
[22] Richard G. W. Anderson,et al. Annexin VI is required for budding of clathrin-coated pits , 1992, Cell.
[23] B. Hokland,et al. Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading of cells. , 1992, The Journal of biological chemistry.
[24] G. Rogler,et al. HDL3-retroendocytosis in cultured small intestinal crypt cells: a novel mechanism of cholesterol efflux. , 1991, Biochimica et biophysica acta.
[25] S. Yokoyama,et al. Interaction of free apolipoproteins with macrophages. Formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. , 1991, The Journal of biological chemistry.
[26] S. Eisenberg,et al. Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. , 1989, The Journal of clinical investigation.
[27] J. Oram,et al. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. , 1987, The Journal of biological chemistry.
[28] S. Zigmond,et al. Inhibition of receptor-mediated but not fluid-phase endocytosis in polymorphonuclear leukocytes , 1985, The Journal of cell biology.
[29] G. Assmann,et al. Interaction of high density lipoproteins with cholesteryl ester‐laden macrophages: biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages. , 1985, The EMBO journal.
[30] N. Tolbert,et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.
[31] J. Genest,et al. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. , 1999, Arteriosclerosis, thrombosis, and vascular biology.